Nuvalent (NUVL) PT Lowered to $172 at Bernstein SocGen Group
Bernstein SocGen Group analyst Jeffrey Walch lowered the price target on Nuvalent (NASDAQ: NUVL) to $172.00 (from $189.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
